The cordycepin group, doxorubicin group and combined group could regulate the EMT process by regulating EMT markers (e.g., N-cadherin, E-cadherin, ZEB1, Twist1) and could inhibit the expression of proteins related to tumor migration. Here, CDH2 is linked to neoplasm.